Clover Health [CLOV] vs Elevance Health [ELV] Detailed Stock Comparison
Clover Health
NASDAQ
Loading...
Elevance Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Clover Health wins in 3 metrics, Elevance Health wins in 14 metrics, with 0 ties. Elevance Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Clover Health | Elevance Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -32.37 | 14.86 | Clover Health |
| Price-to-Book Ratio | 3.84 | 1.80 | Elevance Health |
| Debt-to-Equity Ratio | 0.00 | 68.84 | Clover Health |
| PEG Ratio | 0.11 | -0.68 | Elevance Health |
| EV/EBITDA | -27.43 | 7.85 | Clover Health |
| Profit Margin (TTM) | -2.68% | 2.83% | Elevance Health |
| Operating Margin (TTM) | -2.21% | 5.29% | Elevance Health |
| EBITDA Margin (TTM) | N/A | 5.29% | N/A |
| Return on Equity | -12.59% | 12.42% | Elevance Health |
| Return on Assets (TTM) | -4.26% | 4.65% | Elevance Health |
| Free Cash Flow (TTM) | $33.29M | $4.55B | Elevance Health |
| Dividend Yield | N/A | 1.32% | N/A |
| 1-Year Return | -35.89% | -28.77% | Elevance Health |
| Price-to-Sales Ratio (TTM) | 0.83 | 0.42 | Elevance Health |
| Enterprise Value | $1.13B | $74.45B | Elevance Health |
| EV/Revenue Ratio | 0.70 | 0.39 | Elevance Health |
| Gross Profit Margin (TTM) | 20.86% | N/A | N/A |
| Revenue per Share (TTM) | $3 | $829 | Elevance Health |
| Earnings per Share (Diluted) | $-0.08 | $23.58 | Elevance Health |
| Beta (Stock Volatility) | 2.11 | 0.59 | Elevance Health |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Clover Health vs Elevance Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Clover Health | 1.16% | -19.06% | -2.63% | 1.17% | -26.21% | -17.25% |
| Elevance Health | -0.16% | 10.01% | 8.99% | 0.76% | -22.57% | -4.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Clover Health | -35.89% | 64.97% | -75.50% | -74.61% | -74.61% | -74.61% |
| Elevance Health | -28.77% | -24.96% | 19.05% | 149.48% | 537.16% | 372.37% |
News Based Sentiment: Clover Health vs Elevance Health
Clover Health
News based Sentiment: NEGATIVE
October was a turbulent month for Clover Health, dominated by stock declines triggered by regulatory concerns surrounding ACA tax credits and a notable insider sale by the CEO. While institutional investors increased their holdings, the negative sentiment stemming from policy uncertainty and insider activity overshadows these positive developments, making it a significant month for investors to assess the company's risk profile.
Elevance Health
News based Sentiment: MIXED
Elevance Health is facing both positive and negative developments this month. While institutional investment and reaffirmed guidance are encouraging, the lawsuit, enrollment declines, and expected earnings decrease create uncertainty. The overall narrative suggests a company navigating challenges while maintaining a reasonably strong position.
Performance & Financial Health Analysis: Clover Health vs Elevance Health
| Metric | CLOV | ELV |
|---|---|---|
| Market Information | ||
| Market Cap | $1.62B | $78.92B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 11,497,670 | 1,900,110 |
| 90 Day Avg. Volume | 7,062,627 | 2,032,487 |
| Last Close | $2.62 | $349.94 |
| 52 Week Range | $2.12 - $4.87 | $273.71 - $510.24 |
| % from 52W High | -46.20% | -31.42% |
| All-Time High | $28.85 (Jun 07, 2021) | $567.26 (Sep 02, 2024) |
| % from All-Time High | -90.92% | -38.31% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.34% | 0.14% |
| Quarterly Earnings Growth | 0.34% | -0.24% |
| Financial Health | ||
| Profit Margin (TTM) | -0.03% | 0.03% |
| Operating Margin (TTM) | -0.02% | 0.05% |
| Return on Equity (TTM) | -0.13% | 0.12% |
| Debt to Equity (MRQ) | 0.00 | 68.84 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.67 | $194.46 |
| Cash per Share (MRQ) | $0.39 | $154.51 |
| Operating Cash Flow (TTM) | $-46,732,000 | $6.45B |
| Levered Free Cash Flow (TTM) | $83.15M | $12.05B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.32% |
| Last 12-Month Dividend | N/A | $4.97 |
Valuation & Enterprise Metrics Analysis: Clover Health vs Elevance Health
| Metric | CLOV | ELV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -32.37 | 14.86 |
| Forward P/E | -18.50 | 10.03 |
| PEG Ratio | 0.11 | -0.68 |
| Price to Sales (TTM) | 0.83 | 0.42 |
| Price to Book (MRQ) | 3.84 | 1.80 |
| Market Capitalization | ||
| Market Capitalization | $1.62B | $78.92B |
| Enterprise Value | $1.13B | $74.45B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.70 | 0.39 |
| Enterprise to EBITDA | -27.43 | 7.85 |
| Risk & Other Metrics | ||
| Beta | 2.11 | 0.59 |
| Book Value per Share (MRQ) | $0.67 | $194.46 |
Financial Statements Comparison: Clover Health vs Elevance Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CLOV | ELV |
|---|---|---|
| Revenue/Sales | $462.33M | $49.78B |
| Cost of Goods Sold | $353.44M | N/A |
| Gross Profit | $108.89M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-1.27M | N/A |
| EBITDA | $-808,000 | N/A |
| Pre-Tax Income | $-1.27M | $2.29B |
| Income Tax | N/A | $548.00M |
| Net Income (Profit) | $-1.27M | $1.74B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CLOV | ELV |
|---|---|---|
| Cash & Equivalents | $155.44M | $8.56B |
| Total Current Assets | $331.41M | N/A |
| Total Current Liabilities | $215.65M | N/A |
| Long-Term Debt | N/A | $28.18B |
| Total Shareholders Equity | $336.08M | $43.85B |
| Retained Earnings | $-2.20B | $35.55B |
| Property, Plant & Equipment | $5.03M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CLOV | ELV |
|---|---|---|
| Operating Cash Flow | $-24.27M | $1.77B |
| Capital Expenditures | $-185,000 | $-267.00M |
| Free Cash Flow | $-16.48M | $1.79B |
| Debt Repayment | N/A | $110.00M |
| Common Stock Repurchase | $-31.96M | $-378.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CLOV | ELV |
|---|---|---|
| Shares Short | 49.28M | 3.68M |
| Short Ratio | 9.76 | 1.71 |
| Short % of Float | 0.12% | 0.02% |
| Average Daily Volume (10 Day) | 11,497,670 | 1,900,110 |
| Average Daily Volume (90 Day) | 7,062,627 | 2,032,487 |
| Shares Outstanding | 503.53M | 227.48M |
| Float Shares | 400.54M | 224.66M |
| % Held by Insiders | 0.04% | 0.00% |
| % Held by Institutions | 0.35% | 0.93% |
Dividend Analysis & Yield Comparison: Clover Health vs Elevance Health
| Metric | CLOV | ELV |
|---|---|---|
| Last 12-Month Dividend | N/A | $4.97 |
| Last 12-Month Dividend Yield | N/A | 1.32% |
| 3-Year Avg Annual Dividend | N/A | $5.08 |
| 3-Year Avg Dividend Yield | N/A | 0.32% |
| 3-Year Total Dividends | N/A | $15.23 |
| Ex-Dividend Date | N/A | Mar 10, 2025 |